Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-18-031952

Chief Scientific Officer sold 11,485 shares at $4.05 ($46,487)

  • Chief Scientific Officer acquired 11,485 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ettenberg Seth Chief Scientific Officer 2018-12-26 Option exercise +11,485 $0.18 $2,067 11,485 D: show line 1 in the form
Ettenberg Seth Chief Scientific Officer 2018-12-26 Sale −11,485 $4.05 $46,487 0 D: show line 2 in the form
Open-market sales · 11,485 sh · avg $4.05 · $46,487

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ettenberg Seth Chief Scientific Officer 2018-12-26 Option exercise · Stock Option (Right to Buy) −11,485 352,115 D: show line 3 in the form
Loading xslF345X03/doc4.xml…